Portfolio Holdings Detail for ISIN IE00B3VWM098

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE

Holdings detail for GKOS

Show aggregate GKOS holdings

News associated with GKOS

Zacks Research Weighs in on Glaukos’ Q3 Earnings (NYSE:GKOS)

Glaukos Corporation (NYSE:GKOS – Free Report) – Investment analysts at Zacks Research lowered their Q3 2026 earnings per share (EPS) estimates for Glaukos in a note issued to investors on Wednesday, August 20th. Zacks Research analyst Team now expects that the medical instruments supplier will post earnings per share of $0.02 for the quarter, down […] - 2025-08-25 03:02:49

Vanguard Group Inc. Has $587.09 Million Holdings in Glaukos Corporation (NYSE:GKOS)

Vanguard Group Inc. lowered its stake in Glaukos Corporation (NYSE:GKOS – Free Report) by 0.2% in the first quarter, Holdings Channel.com reports. The institutional investor owned 5,965,115 shares of the medical instruments supplier’s stock after selling 9,856 shares during the quarter. Vanguard Group Inc. owned approximately 0.10% of Glaukos worth $587,087,000 as of its most […] - 2025-08-14 04:37:10

Natixis Advisors LLC Cuts Stock Position in Glaukos Corporation (NYSE:GKOS)

Natixis Advisors LLC lowered its holdings in shares of Glaukos Corporation (NYSE:GKOS – Free Report) by 12.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 29,871 shares of the medical instruments supplier’s stock after selling 4,428 shares during the quarter. Natixis […] - 2025-08-07 04:49:06

Thornburg Investment Management Inc. Has $4.96 Million Stake in Glaukos Corporation (NYSE:GKOS)

Thornburg Investment Management Inc. increased its stake in shares of Glaukos Corporation (NYSE:GKOS – Free Report) by 10.6% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 50,430 shares of the medical instruments supplier’s stock after acquiring an additional 4,847 shares during the period. Thornburg […] - 2025-07-30 04:58:52

KLP Kapitalforvaltning AS Has $1.07 Million Stock Position in Glaukos Corporation (NYSE:GKOS)

KLP Kapitalforvaltning AS lessened its stake in Glaukos Corporation (NYSE:GKOS – Free Report) by 4.4% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,900 shares of the medical instruments supplier’s stock after selling 500 shares during the quarter. KLP Kapitalforvaltning AS’s holdings […] - 2025-07-29 05:27:00

4,853 Shares in Glaukos Corporation (NYSE:GKOS) Acquired by Y Intercept Hong Kong Ltd

Y Intercept Hong Kong Ltd acquired a new position in shares of Glaukos Corporation (NYSE:GKOS – Free Report) in the 1st quarter, HoldingsChannel.com reports. The fund acquired 4,853 shares of the medical instruments supplier’s stock, valued at approximately $478,000. Several other hedge funds and other institutional investors have also recently bought and sold shares of […] - 2025-07-28 08:10:46

Envestnet Asset Management Inc. Decreases Holdings in Glaukos Corporation (NYSE:GKOS)

Envestnet Asset Management Inc. decreased its position in shares of Glaukos Corporation (NYSE:GKOS – Free Report) by 27.8% during the 1st quarter, Holdings Channel.com reports. The fund owned 28,038 shares of the medical instruments supplier’s stock after selling 10,817 shares during the period. Envestnet Asset Management Inc.’s holdings in Glaukos were worth $2,760,000 at the […] - 2025-07-28 04:28:50

Glaukos Corporation (NYSE:GKOS) Shares Acquired by Victory Capital Management Inc.

Victory Capital Management Inc. lifted its holdings in shares of Glaukos Corporation (NYSE:GKOS – Free Report) by 88.7% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 140,411 shares of the medical instruments supplier’s stock after buying an additional 66,009 shares during the period. Victory Capital […] - 2025-07-24 05:00:46

4,146 Shares in Glaukos Corporation (NYSE:GKOS) Purchased by OneAscent Financial Services LLC

OneAscent Financial Services LLC bought a new position in Glaukos Corporation (NYSE:GKOS – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 4,146 shares of the medical instruments supplier’s stock, valued at approximately $408,000. A number of other hedge funds also recently […] - 2025-07-23 06:45:09

Mutual of America Capital Management LLC Sells 324 Shares of Glaukos Corporation (NYSE:GKOS)

Mutual of America Capital Management LLC decreased its position in Glaukos Corporation (NYSE:GKOS – Free Report) by 3.9% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 8,029 shares of the medical instruments supplier’s stock after selling 324 shares during the period. Mutual of […] - 2025-07-22 07:06:53

Glaukos Corporation (NYSE:GKOS) Shares Acquired by Avior Wealth Management LLC

Avior Wealth Management LLC boosted its position in Glaukos Corporation (NYSE:GKOS – Free Report) by 30.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,384 shares of the medical instruments supplier’s stock after buying an additional 782 shares during the quarter. […] - 2025-06-23 05:51:04

Glaukos Corporation (NYSE:GKOS) Stake Trimmed by Trust Point Inc.

Trust Point Inc. cut its position in shares of Glaukos Corporation (NYSE:GKOS – Free Report) by 53.7% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,999 shares of the medical instruments supplier’s stock after selling 3,481 shares during the quarter. Trust Point Inc.’s […] - 2025-06-18 05:52:52

Glaukos Corporation (NYSE:GKOS) Receives Consensus Rating of “Moderate Buy” from Analysts

Glaukos Corporation (NYSE:GKOS – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the twelve brokerages that are presently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and ten have assigned a buy recommendation to the […] - 2025-06-18 02:52:53

Versant Capital Management Inc Purchases 327 Shares of Glaukos Co. (NYSE:GKOS)

Versant Capital Management Inc boosted its position in shares of Glaukos Co. (NYSE:GKOS – Free Report) by 583.9% in the first quarter, Holdings Channel.com reports. The institutional investor owned 383 shares of the medical instruments supplier’s stock after acquiring an additional 327 shares during the period. Versant Capital Management Inc’s holdings in Glaukos were worth […] - 2025-06-06 05:44:58

Cetera Investment Advisers Reduces Stock Position in Glaukos Co. (NYSE:GKOS)

Cetera Investment Advisers lessened its holdings in Glaukos Co. (NYSE:GKOS – Free Report) by 46.5% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 1,504 shares of the medical instruments supplier’s stock after selling 1,309 shares during the quarter. Cetera Investment Advisers’ holdings in Glaukos were worth $226,000 as of its most recent SEC […] - 2025-06-02 04:34:59

Royal Bank of Canada Cuts Stake in Glaukos Co. (NYSE:GKOS)

Royal Bank of Canada reduced its position in Glaukos Co. (NYSE:GKOS – Free Report) by 41.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 112,310 shares of the medical instruments supplier’s stock after selling 79,841 shares during the quarter. Royal Bank of […] - 2025-05-26 05:27:10

Focus Partners Wealth Invests $379,000 in Glaukos Co. (NYSE:GKOS)

Focus Partners Wealth purchased a new position in shares of Glaukos Co. (NYSE:GKOS – Free Report) in the 4th quarter, Holdings Channel.com reports. The firm purchased 2,528 shares of the medical instruments supplier’s stock, valued at approximately $379,000. Other large investors have also modified their holdings of the company. Rhumbline Advisers raised its stake in […] - 2025-05-22 05:08:53

Analysts See 18% Gains Ahead For USVM

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-20 07:56:36

Glaukos (NYSE:GKOS) Given New $72.00 Price Target at Morgan Stanley

Glaukos (NYSE:GKOS – Get Free Report) had its price objective decreased by stock analysts at Morgan Stanley from $110.00 to $72.00 in a report released on Tuesday,Benzinga reports. The brokerage currently has an “underweight” rating on the medical instruments supplier’s stock. Morgan Stanley’s price objective suggests a potential downside of 18.40% from the company’s current […] - 2025-05-08 05:00:57

Mariner LLC Sells 783 Shares of Glaukos Co. (NYSE:GKOS)

Mariner LLC cut its holdings in Glaukos Co. (NYSE:GKOS – Free Report) by 11.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,249 shares of the medical instruments supplier’s stock after selling 783 shares during the period. Mariner […] - 2025-04-28 05:08:52

Barclays PLC Acquires 2,086 Shares of Glaukos Co. (NYSE:GKOS)

Barclays PLC lifted its holdings in shares of Glaukos Co. (NYSE:GKOS – Free Report) by 2.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 91,785 shares of the medical instruments supplier’s stock after purchasing an additional 2,086 shares during the quarter. Barclays PLC’s holdings […] - 2025-04-21 05:38:46

Raymond James Financial Inc. Acquires Shares of 112,771 Glaukos Co. (NYSE:GKOS)

Raymond James Financial Inc. bought a new position in Glaukos Co. (NYSE:GKOS – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 112,771 shares of the medical instruments supplier’s stock, valued at approximately $16,910,000. Several other institutional investors […] - 2025-04-21 04:40:47

Schroder Investment Management Group Acquires 6,991 Shares of Glaukos Co. (NYSE:GKOS)

Schroder Investment Management Group grew its holdings in Glaukos Co. (NYSE:GKOS – Free Report) by 213.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,259 shares of the medical instruments supplier’s stock after purchasing an additional 6,991 shares during […] - 2025-04-07 05:12:52

Pictet Asset Management Holding SA Purchases 1,041 Shares of Glaukos Co. (NYSE:GKOS)

Pictet Asset Management Holding SA lifted its position in Glaukos Co. (NYSE:GKOS – Free Report) by 15.9% in the 4th quarter, Holdings Channel.com reports. The fund owned 7,582 shares of the medical instruments supplier’s stock after acquiring an additional 1,041 shares during the period. Pictet Asset Management Holding SA’s holdings in Glaukos were worth $1,137,000 […] - 2025-04-06 06:25:02

Norges Bank Takes Position in Glaukos Co. (NYSE:GKOS)

Norges Bank purchased a new position in shares of Glaukos Co. (NYSE:GKOS – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 563,493 shares of the medical instruments supplier’s stock, valued at approximately $84,490,000. A number of other hedge funds […] - 2025-04-03 05:36:55

Glaukos Co. (NYSE:GKOS) Stock Position Lowered by Corebridge Financial Inc.

Corebridge Financial Inc. decreased its position in Glaukos Co. (NYSE:GKOS – Free Report) by 7.2% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 26,274 shares of the medical instruments supplier’s stock after selling 2,051 shares during the period. Corebridge Financial Inc.’s holdings in Glaukos were worth […] - 2025-03-31 05:49:01

Congress Wealth Management LLC DE Sells 400 Shares of Glaukos Co. (NYSE:GKOS)

Congress Wealth Management LLC DE reduced its stake in Glaukos Co. (NYSE:GKOS – Free Report) by 22.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,389 shares of the medical instruments supplier’s stock after selling 400 shares during the period. […] - 2025-03-31 05:14:58

Glaukos Co. (NYSE:GKOS) Shares Bought by Xponance Inc.

Xponance Inc. boosted its position in shares of Glaukos Co. (NYSE:GKOS – Free Report) by 13.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,633 shares of the medical instruments supplier’s stock after buying an additional 426 shares during the quarter. Xponance Inc.’s […] - 2025-03-26 05:56:54

Sequoia Financial Advisors LLC Trims Stock Holdings in Glaukos Co. (NYSE:GKOS)

Sequoia Financial Advisors LLC lowered its holdings in Glaukos Co. (NYSE:GKOS – Free Report) by 6.2% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,773 shares of the medical instruments supplier’s stock after selling 117 shares during the period. Sequoia Financial Advisors LLC’s holdings in […] - 2025-03-20 06:40:56

Analysts Set Glaukos Co. (NYSE:GKOS) Price Target at $163.25

Glaukos Co. (NYSE:GKOS – Get Free Report) has earned an average rating of “Moderate Buy” from the thirteen ratings firms that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, eleven have given a buy recommendation and one has given a strong buy recommendation to […] - 2025-03-13 04:06:47

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc GKOS holdings

Date	Number of GKOS Shares Held	Base Market Value of GKOS Shares	Local Market Value of GKOS Shares	Change in GKOS Shares Held	Change in GKOS Base Value	Current Price per GKOS Share Held	Previous Price per GKOS Share Held
2025-09-29 (Monday)	54,233	USD 4,408,058	USD 4,408,058
2025-09-26 (Friday)	54,233	USD 4,334,301	USD 4,334,301
2025-09-25 (Thursday)	54,233	USD 4,418,363	USD 4,418,363	0	USD -71,587	USD 81.47	USD 82.79
2025-09-24 (Wednesday)	54,233	USD 4,489,950	USD 4,489,950
2025-09-17 (Wednesday)	53,881	USD 4,423,630	USD 4,423,630	0	USD -13,470	USD 82.1	USD 82.35
2025-09-16 (Tuesday)	53,881	USD 4,437,100	USD 4,437,100
2025-09-12 (Friday)	53,529	USD 4,430,060	USD 4,430,060

Share Trades of GKOS by Blackrock for IE00B3VWM098

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-08-21	SELL	-168			89.790*		113.50 Profit of 19,069 on sale
2025-07-31	BUY	504			86.090*		113.81
2025-07-28	SELL	-168			94.920*		114.17 Profit of 19,180 on sale
2025-06-30	SELL	-336			103.290*		115.76 Profit of 38,894 on sale
2025-06-25	SELL	-168			99.310*		116.08 Profit of 19,501 on sale
2025-06-20	SELL	-336			100.150*		116.44 Profit of 39,124 on sale
2025-05-23	BUY	168			96.020*		119.78
2025-05-19	SELL	-168			95.850*		120.59 Profit of 20,258 on sale
2025-05-16	BUY	1,192			95.470*		120.80
2025-05-15	SELL	-492			91.620*		121.06 Profit of 59,561 on sale
2025-05-12	SELL	-164			94.640*		121.82 Profit of 19,979 on sale
2025-05-09	SELL	-164			89.960*		122.11 Profit of 20,026 on sale
2025-04-30	SELL	-164			94.250*		124.41 Profit of 20,403 on sale
2025-04-24	SELL	-328			95.430*		125.60 Profit of 41,197 on sale
2025-04-17	SELL	-164			90.260*		127.48 Profit of 20,907 on sale
2025-04-15	SELL	-492			94.520*		128.26 Profit of 63,103 on sale
2025-04-14	SELL	-492			92.910*		128.65 Profit of 63,295 on sale
2025-04-09	SELL	-656			93.550*		129.93 Profit of 85,233 on sale
2025-04-07	SELL	-1,148			86.070*		130.99 Profit of 150,379 on sale
2025-04-04	SELL	-1,650			83.650*		131.55 Profit of 217,056 on sale
2025-03-31	BUY	165			98.420*		132.76
2025-03-19	SELL	-330			101.240*		135.93 Profit of 44,856 on sale
2025-03-14	SELL	-990			102.190*		137.36 Profit of 135,987 on sale
2025-03-13	SELL	-330			96.600*		137.94 Profit of 45,521 on sale
2025-03-12	SELL	-5,610			103.340*		138.44 Profit of 776,674 on sale
2025-03-07	SELL	-330			104.190*		140.21 Profit of 46,270 on sale
2025-03-06	SELL	-495			103.200*		140.78 Profit of 69,687 on sale
2025-03-04	BUY	1,002			112.210*		141.69
2025-03-03	SELL	-163			109.150*		142.22 Profit of 23,181 on sale
2025-02-28	SELL	-978			120.020*		142.58 Profit of 139,442 on sale
2025-02-26	SELL	-163			120.490*		143.36 Profit of 23,368 on sale
2025-02-25	SELL	-489			120.510*		143.76 Profit of 70,298 on sale
2025-02-18	BUY	815			152.960*		143.72
2025-02-13	BUY	163			146.380*		143.28
2025-02-12	BUY	163			143.640*		143.28
2025-02-11	BUY	489			145.340*		143.23
2025-02-06	BUY	1,458			155.280*		142.60
2025-01-30	BUY	779			157.750*		140.88
2025-01-27	BUY	160			157.030*		139.44
2024-12-30	BUY	800			149.510*		137.54
2024-12-06	BUY	640			140.280*		137.45
2024-12-05	BUY	160			135.700*		137.51
2024-12-04	BUY	800			138.270*		137.48
2024-11-29	BUY	800			143.650*		137.23
2024-11-27	BUY	640			142.690*		136.76
2024-11-26	BUY	160			140.730*		136.57
2024-11-25	BUY	8,540			142.940*		136.27
2024-11-21	BUY	670			140.830*		135.62
2024-11-20	BUY	402			141.440*		135.30
2024-11-18	BUY	1,608			136.980*		134.64
2024-11-12	BUY	1,064			143.630*		134.04
2024-11-08	BUY	665			141.750*		133.49
2024-11-07	BUY	1,995			139.330*		133.04
2024-11-06	BUY	266			140.640*		132.41
2024-10-31	BUY	133			132.250*		133.20

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of GKOS

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer